Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Confidence intervals are close to 1 (no significant diff). Reduce it is going to be close at first look at this.
Qs- See prior post by me on Adcom. Anyone have a comment or answer to this. Thanks in advance.
Can someone explain what this Adcom is and how that works ? I was under impression it was called for by a company for drug approval and or label expansion not just done out of blue as is suggested here. Sorta confusing.
Thanks.
You really think amrn is going to wait for FDA to release results. I don’t see that as a possibility. I see it as necessary afterwards but we won’t get that with the news release. my opinion.
Monday can be the day. I can’t see this going much further.
Best post today. Well stated. For those that have thought this is about reduction of TG, they don’t know what they are invested in.
I remain bullish despite the misconstrued seeking alpha post. It’s all games to the bears. If anyone sold on those posts, I am very sorry. No info has changed in months. Hold for the results and you will be pleasantly surprised.
Good luck
I don’t plan on converting to shares necessarily but rather just selling the calls as the stock climbs after AHA update. The Jan call options are there for a longer play into Jan with my shares possibly being sold in coming weeks. However I may not even be selling shares. Depends how I interpret the results. If we get mace and death reduction I’m holding all.
Thanks for your reply. Most of my position is in stock. I wanted extra leverage for Jan in the event I wait for AHA guideline update end of year which should send this up another level.
What’s a realistic premium for the Jan 4 dollar calls now at ~1.20 if amrn shoots to 15 bucks on results for those who play options a lot ?
Thx
ITC decision 90 d is 9/6.
Favorable response prior to reduce it read out will send this to the moon.
I don’t see anything different in this presentation from prior. What was point in them posting this ?
Getting news Tuesday would be amazing. No time for manipulation or bear raid. Any other day after that we can get manipulation prior to any news break.
Crossing fingers for Tuesday. It is possible but unlikely.
This is effd.
Does this apply to big hedge funds as well using TDA? No margin for all on this stock ? I would think this would have had bigger effect on stock price
Why that date ?
If Monday’s CC was including R IT why wouldn’t they just state so. Markets closed anyway. I doubt they are releasing Monday. It’s going to come as a surprise when they release reduce it.
Problem is that’s a diff population. In reduce it I think only half will have low HDL in addition to the high tgs
I thought epanova was holding off due to amrn patents. You think they would launch despite amrn patents? Either way first to market for amrn would be a major advantage.
FFS- you probably understand this the best. But you think for NO odd reason amrn trades one of its highest volumes in the past year and mostly at 3.09 all day with just coincidence of a buy and sell equilibrium. Sorry for my ignorance, just seems like something or someone is doing something to make that happen rather than just pure chance.
the result. Timing is very hard to predict as you probably know.
I am wondering the same. I wish I knew how this market manipulation worked. How do they profit from holding the stock at 3.09 all day on high volume.
The judges are not waiting. Decision will come in August or sept and will very likely be in our favor - as per my lawyer Friend with great knowledge of this.
I think your points are good ones. It’s good to look at it from both sides. My feeling is if you truly believe that you should be out of this stock a long time ago.
You can’t really believe that. The street can’t be that ignorant. A blockbuster study with tremendous success has to get this to 15-20. I hope I am not wrong but I can’t see the stock staying at 3-4 bucks with a positive reduce it study and the AHA guideline update pending in Q4. The FDA label is a key point but that can be months to a year away. who knows.
What do you think they release on the initial top line results.
Will they give us primary and secondary endpoints or just primary met at this RRR.
I want it to be a strong statement.
It’s 200 bucks for all the ppts from yesterday’s lecture on amrn. I winded up not buying it but if someone did let us know.
The rep to email is k.pamfil@americanconference.com
June 19th.
Case Study on the Future of Fish Oil: Exploring The Consequences of Retroactively Declaring a Dietary Supplement a Drug
Anyone going to be able to get the audio to this lecture.
The oral arguments heavily favor amrn. I just hope we get an initiation of ITC investigation PRIOR to reduce it read out. That would be a real nice thing. Can anyone comment on timing ?
Such bs they can do this.
Regarding that June conf
“Case Study on the Future of Fish Oil: Exploring The Consequences of Retroactively Declaring a Dietary Supplement a Drug “
I wonder what side these folks are going to be on ? This lecture is June 19th 430 pm. Not sure I’ll be able to make it but this will be a pretty interesting lecture to listen to.
This looks fairly bullish. Next Thursday Friday conf call and oral arguments maybe the reason ?
You never know with amrn.
He’s been wrong 1000 times. Waste of time reading anything he writes. He should be banned.
Nice find. Nice law suit. This is just all favoring amrn so much. Crazy to see the stock trade so low. Hang on longs.
I wonder what AZN is doing. They are still years out from strength trial final results And just sitting on the sidelines.
It was on cbs in Ny and Nj. Idk where else everyone is from.
I can’t see this link. Says it no longer exists. They updated their guidance to allow easier rescindments of spa? Or am I interpreting you guys wrong?
Thx mAkes sense
How do you know this is bullish. The option price on those barely moved today despite the insanely high volume on those. I’ve followed those for awhile and have a large number of the 4 dollar calls. Usually there’s only a few contracts a day in volume with a very wide bid/ask. Good this is pointed out with all the increase in volume but I am not sure what it means.
Hopefully bullish.
The lowest of risk may skate by but I’ll tell you a LARGE percentage of people that don’t fit the inclusjon criteria for reduce it will be prescribed Vascepa especially when it becomes part of the AHA guidelines (assuming amazing reduce it results ). It will be prescribed both for primary and secondary prevention without a doubt Insurance carriers will pick it up if it’s as good as we hope it to be and the evidence out there supports.
Have to interject here as a physician. Interesting points but the leap to prescribing Vascepa to those with trigs >150 will be very easy AS LONG AS reduce it is a slam dunk. Drugs RARELY only get prescribed for the exact patient population studied in the trial. Literature is extrapolated to include alternative bigger patient populations in order to capture as many patients as possible that could benefit.
Hope that makes sense. This will be a huge hit across many specialities if it does what we all know it will.
Where’s the conf call info anyone have a link for today.
If amrn eventually wins and ITC forced to investigate and amrn is determined to be correct regarding labeling claims, do you think supplements can change their labels to just say fish oil or will there need to be a payout to amrn. I see a tough road but amrn coming out ahead.